Marella Thorell
CIK 1826323 · See Remarks · last filed 2026-07-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
6
Total Filings
26
Lifetime Open-Market Net
-$5.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCRB | See Remarks | — | $4.80 | — | $0 | 4 | 2026-07-10 |
| Carisma Therapeutics Inc. (CARM) Delisted | Director | — | $0.00 | — | $0 | 1 | 2024-07-01 |
| ESSA Pharma Inc. (EPIX) Delisted | Director | — | $0.20 | — | $0 | 4 | 2024-03-28 |
| Evelo Biosciences, Inc. (EVLO) Delisted | Chief Financial Officer | 22,259 | $0.00 | $2 | -$25.8K | 8 | 2023-11-08 |
| GRI Bio, Inc. (VLON) Delisted | Director | 317 | $12.00 | $3.8K | $0 | 4 | 2022-12-15 |
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Accounting Officer | 53,101 | $40.50 | $2.15M | $20.0K | 4 | 2022-03-23 |
Recent Filings · Page 3 of 3
26 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-03 | Centessa Pharmaceuticals plc (CNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | Centessa Pharmaceuticals plc (CNTA) Delisted | Buy (P) | +1,000 | $20.0K | EDGAR |
| 2021-06-01 | Centessa Pharmaceuticals plc (CNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-12 | GRI Bio, Inc. (VLON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-26 | ESSA Pharma Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-11 | ESSA Pharma Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–26 of 26
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.